Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small – Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01)
暂无分享，去创建一个
A. Vergnenègre | C. Dubos-Arvis | P. Thomas | I. Monnet | N. Paleiron | O. Bylicki | G. Fraboulet | P. Thomas | J. Auliac | M. Marcq | B. Comet | A. Madroszyk | J. Le Treut | J. Crequit | V. Basse | G. Le Garff | J. L. Treut | G. L. Garff